Elizabeth Berry

Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center

J. Sosman, Douglas B. Johnson, I. Puzanov, 2015, Cancer Immunology Research.

Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies

A. Iafrate, R. Sullivan, J. Sosman, 2015, Cancer Immunology Research.

Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials

William Pao, Mark C. Kelley, Ann Richmond, 2012, PloS one.

NRAS mutation: A potential biomarker of clinical response to immune-based therapies in metastatic melanoma (MM).

A. Iafrate, R. Sullivan, J. Sosman, 2013 .